Optibiotix Health Share Discussion Threads

[marnewton] 17/1/2017 20:18

Aye JH, lookin' good;¬)

Cheers,

M

[diamond fibre] 17/1/2017 18:39

Optibiotix 83p. _ skin division 70p at the end of the year?

[diamond fibre] 17/1/2017 18:37

Optibiotix 83p. _ skin division 70p at the end of the year?

[shrewdmole] 17/1/2017 18:34

The trades are telling a story and have been for a couple of weeks.

Buys seem bulkier balanced by smaller bored sellers.

[rafboy] 17/1/2017 18:32

So our seller is revealed and he still holds far far more than most of us on here. Without looking at this via the old "rose tints" this is good news. Seller done so no drag on the share price. An ex chairman who has retained over a 2 million share holding. Perhaps this explains why we are now moving forward without taking a few more steps back.

[parob] 17/1/2017 18:26

Thanks for confirming JH. Looks like we'll have nothing to hold us back on the next piece of good news.

[john henry] 17/1/2017 18:07

Technicals looking good Mar, I notice the 10 day has punched decisively through the 50 for the first time since falling through middle of June last year. Positive test day and EOD candle.starting to look very positive. Another higher weekly close and change in trend more or less confirmed. Close above 74p, yabba dabba do

[whl2] 17/1/2017 17:57

Great guy actually,he did a cracking job with Shields Diagnostics. Made a few bob with them over the years before their merger

[john henry] 17/1/2017 17:56

Parob, any major holder reducing their position will declare once they have completed. We now know where the overhang has come from and that it has been cleared.

[owenmo] 17/1/2017 17:47

Evans above! beat that for a cv.
Now tell me he was a single-figure handicap golfer.

[shrewdmole] 17/1/2017 17:37

It was fincap the company broker that said the seller they knew of wouldn't sell anymore at these levels.

So sounds like he's done for now.

Sm

[neftanikoff] 17/1/2017 17:35

yes Griffin, thanks anyhow.

[neftanikoff] 17/1/2017 17:34

looks like he sold 855,215 shares for about 600K to leave him still with 3.4%, if that is right.

[griffin81] 17/1/2017 17:33

David Evans reduced his holding from 4.5% to 3.4%, he still holds 2,623,517 shares

[neftanikoff] 17/1/2017 17:25

So i see he was a previous Chairman of opti. Be interesting to know why he has sold, is it his entire holding, at just the time we are expecting major developments for the company.

[parob] 17/1/2017 17:16

So that's why we've had the down trend. Just over 850K shares sold including last Friday when we had the high volume day.Am I right in thinking that now this has been declared, he has finished selling?Perhaps this is the historical seller Shrewdie's broker mentioned the other day who doesn't want to sell any more at this level. Would make sense as haven't seen any large sales going through this week.Onwards and upwards!

[1bokke] 17/1/2017 17:13

Sorry for the war and peace but this is who he is.. Mr. David Eric Evans, B.Com., CA, MBA, serves as the Chairman of Management Board of Sirigen Ltd. Mr. Evans has been an Executive Director of EKF Diagnostics Holdings plc since November 26, 2009. He served as the Executive Chairman of EKF Diagnostics Holdings plc from July 2010 to October 23, 2015. Mr. Evans served as the Chief Executive Officer and Head of Axis-Shield Plc. He served as the Chief Executive Officer of Storyland Ltd. He served as the Deputy Chief Executive Officer of Axis-Shield plc. He served as the Managing Director of Shield Diagnostics plc and jointly of Axis-Shield PLC. As Financial Director, he served as a key member of the team that floated Shield Diagnostics Group PLC in 1993 and served as the Chief Executive Officer responsible for the merger of Shield Diagnostics Group PLC with Axis Biochemicals ASA of Norway in 1999 to create Axis Shield plc, which he left in November 2000. He has significant experience within the diagnostics industry. He has considerable expertise within the diagnostic industry. He has a proven track record in acquiring, integrating and growing businesses in the diagnostic area and in value creation. He is an entrepreneurial accountant focusing in early stage and high-growth medical diagnostics and life science companies. Mr. Evans is a widely respected figure in UK diagnostics business having floated three companies on AIM and one on the Main Market and taken companies such as British Biocell to significant acquisition values by multinational players. He has a substantial track record in both taking companies through the IPO process (as Chairman) and delivering value to shareholders in the public phase of a company. He achieved successful exits for BBI (4x) and Scipac (exit achieved within 12 months of joining) as well as creating substantial uplifts in value for Epistem (3x) DxS (10x) and IDS (18x). He also has substantial experience of M&A activity including cross-border with over 20 transactions in the diagnostics/life sciences space. He served as the Chairman of OptiBiotix Health plc. until August 25, 2016. He has been the Chairman of Quotient Diagnostics, Ltd. since April 2008. He has been the Chairman of Sirigen, Inc. since November 2010. He has been the Non Executive Chairman of Omega Diagnostics Group Plc since August 2000. He serves as the Chairman of Healthcare Investment Opportunities Plc. He serves as the Chairman of Venn Life Sciences Holdings Limited. He serves as the Chairman of Momentum Bioscience Ltd. He serves as the Non-Executive Chairman of Collagen Solutions PLC. He served as Non-Executive Chairman at Premaitha Health PLC from July 04, 2014 to September 8, 2016. He served as a Director of OptiBiotix Health plc from August 05, 2014 to August 25, 2016. He serves as Director of International Brand Licensing plc, Omega Diagnostics Group Plc and Quotient Diagnostics Ltd. He serves as a Director of Storyland Ltd. He served as the Chairman of Platform Diagnostics Limited. He serves as the chairman of IDS plc. He served as Deputy Non Executive Chairman of EKF Diagnostics Holdings plc since October 23, 2015 until June 02, 2016. He has been an Independent Non-Executive Director of Myconostica Ltd. since October 2010. He has been Director of Collagen Solutions PLC since March 22, 2013. He serves as a Director of Immunodiagnostic Systems Limited. He served as the Non-Executive Chairman and Director of Venn Life Sciences Holdings Plc until January 8,2016. He served as the Chairman of OptiBiotix Health Ltd. Mr. Evans served as the Non-Executive Chairman of Physiomics Plc from August 25, 2005 to September 1, 2006. He served as Non-Executive Chairman of Immunodiagnostic Systems Limited until September 08, 2011. He served as Non-Executive Chairman of ViaLogy plc. He served as Non Executive Chairman of Scancell Holdings Plc until January 7, 2016. He was Chairman of DxS Limited, which was sold in 2009. He served as Chairman of QIAGEN Manchester Ltd. He served as Non-Executive Chairman of BBI Diagnostics Group Limited and served as its Director until January 2001. He served as Chairman of Immunodiagnostic Systems Holdings Plc until September 2011. He served as the Chairman of the Board at EpiStem Holdings Plc from April 2007 to May 11, 2015. He served as a Director of Scancell Holdings Plc from April 15, 2008 to January 7, 2016. He served as Non-Executive Director of Genedrive plc (known as EpiStem Holdings Plc) since June 2005 until May 11, 2015. He served as a Director of Horizon Discovery Group plc. He served as a Director of Venn Life Sciences Holdings Plc from December 14, 2012 to January 2016. He served as a Non-Executive Director of Chromogenex Plc. He served as a Non-Executive Director of Vindon Healthcare Plc from November 2006 to March 23, 2010. Mr. Evans holds an MBA from University of Dundee.

[onedayrodders] 17/1/2017 17:12

FrankWhite17 Jan '17 - 15:55 - 18786 of 18797 1 0
I am a holder BTW but considering a major reduction and moving on to shares that have better momentum.


I did that around 35p for the same reasons ..made fk all really elsewhere and watched OPTI go to £1

[sukithedog] 17/1/2017 17:12

now has 4% not a massive sell down

[frankwhite] 17/1/2017 17:11

Hence my question the only holdings RNSs in over a year have all been sellers!

[sukithedog] 17/1/2017 17:10

David Evans 3,478,732 4.5

[owenmo] 17/1/2017 17:10

And at what level has he been selling?; I couldn't access currypasty's link. Tell us more, please.

[neftanikoff] 17/1/2017 17:05

Why ? who is he?

[john henry] 17/1/2017 16:56

So Evans has been selling.